Search

everythinglearnresearchcommunity

for

Search:↓

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.